SynthesisPloS one2017
Men's perspectives of prostate cancer screening: A systematic review of qualitative studies.
Synthesis in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers, 4 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
44 citing papers in PubMed, 4 syntheses or guidelines pooled it, 87 citations in OpenAlex.
- Qualitative studies on men with prostate cancer: a systematic meta-synthesis.International journal of qualitative studies on health and well-being · 2025Pooled it
- Knowledge of prostate cancer presentation, etiology, and screening practices among women: a mixed-methods systematic review.Systematic reviews · 2021Pooled it
- Prostate care and prostate cancer from the perspectives of undiagnosed men: a systematic review of qualitative research.BMJ open · 2019Pooled it
- Values and preferences of men for undergoing prostate-specific antigen screening for prostate cancer: a systematic review.BMJ open · 2018Pooled it
- Exploring motivations and barriers in prostate cancer screening: lessons from a volunteer-based MRI screening study.Frontiers in public health · 2025Trial
- The effect of information on prostate cancer screening decision process: a discrete choice experiment.BMC health services research · 2020Trial
- Why Most Australians Consider It Valuable to Find Harmless Abnormalities with Diagnostic Tests: A Mixed-Methods Study.Medical decision making : an international journal of the Society for Medical Decision Making · 2026Article
- A Social Media Campaign and Web-Based Survey About Prostate Cancer Genetics: Mixed Methods Study.JMIR cancer · 2025Article
- Men's experiences of the Swedish Organised Prostate Cancer Testing programme: a qualitative study.BJU international · 2025Article
- Engaging for equity: Lessons from a cross-sector partnership addressing prostate cancer risk in the black community.Research involvement and engagement · 2025Article
- Men's Attitudes Towards Participation in Organised Prostate Cancer Testing: An Abductive Thematic Analysis.European urology open science · 2025Article
- Sentiment analysis of cancer screening in Chinese social media: Qualitative studies based on machine learning.PloS one · 2025Article
- Global, regional, and national prevalence of prostate cancer from 1990 to 2021: a trend and health inequality analyses.Frontiers in public health · 2025Article
- Navigating prostate cancer screening in Canada for marginalized men through PSA screening and guidelines adherence A call to action for policymakers.Canadian Urological Association journal = Journal de l'Association des urologues du Canada · 2024Article
- Article
- Navigation-Based Telehealth Informed Decision-Making for Prostate Cancer Screening in Black Men.Current oncology (Toronto, Ont.) · 2024Article
- Factors Influencing Prostate Cancer Screening Intentions in Lebanese Men.Asian Pacific journal of cancer prevention : APJCP · 2024Article
- Effectiveness of a community-based health education intervention on prostate cancer fatalism: a quasi-experimental study.The Pan African medical journal · 2024Article
- Melatonin and Health: Insights of Melatonin Action, Biological Functions, and Associated Disorders.Cellular and molecular neurobiology · 2023Review
- Re-evaluating the diagnostic efficacy of PSA as a referral test to detect clinically significant prostate cancer in contemporary MRI-based image-guided biopsy pathways.Journal of clinical urology · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundProstate cancer is the most commonly diagnosed non-skin cancer in men. Screening for prostate cancer is widely accepted; however concerns regarding the harms outweighing the benefits of screening exist. Although patient's play a pivotal role in the decision making process, men may not be aware of the controversies regarding prostate cancer screening. Therefore we aimed to describe men's attitudes, beliefs and experiences of prostate cancer screening.
methodsSystematic review and thematic synthesis of qualitative studies on men's perspectives of prostate cancer screening. Electronic databases and reference lists were searched to October 2016.
findingsSixty studies involving 3,029 men aged from 18-89 years, who had been screened for prostate cancer by Prostate Specific Antigen (PSA) or Digital Rectal Examination (DRE) and not screened, across eight countries were included. Five themes were identified: Social prompting (trusting professional opinion, motivation from family and friends, proximity and prominence of cancer); gaining decisional confidence (overcoming fears, survival imperative, peace of mind, mental preparation, prioritising wellbeing); preserving masculinity (bodily invasion, losing sexuality, threatening manhood, medical avoidance); avoiding the unknown and uncertainties (taboo of cancer-related death, lacking tangible cause, physiological and symptomatic obscurity, ambiguity of the procedure, confusing controversies); and prohibitive costs.
conclusionsMen are willing to participate in prostate cancer screening to prevent cancer and gain reassurance about their health, particularly when supported or prompted by their social networks or healthcare providers. However, to do so they needed to mentally overcome fears of losing their masculinity and accept the intrusiveness of screening, the ambiguities about the necessity and the potential for substantial costs. Addressing the concerns and priorities of men may facilitate informed decisions about prostate cancer screening and improve patient satisfaction and outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.